Tesla short sellers are down $8 billion in 2020, including $2.5 billion alone from Monday’s pop

Investing

Elon Musk, chief executive officer of Tesla Motors

David Paul Morris | Bloomberg | Getty Images

Investors betting against Tesla‘s stock have lost more than $8 billion since the beginning of the year, according to data from S3 Partners, including nearly $2.5 billion in losses on Monday’s surge alone.

Tesla has more short sellers than any other U.S. stock, S3 says, with over 18% of its publicly available shares sold short. The short sellers are investors who borrow shares from a bank and then sell them, hoping the stock will go down. If it does, then the short sellers buy them back at lower prices and return them to the bank, profiting on the difference.

But the opposite is happening with Tesla. If a stock price instead trends higher, short sellers are forced to buy back the equity at a higher price in order to cut their mounting losses. With shares of Elon Musk’s automaker ripping more than 14% higher in Monday trading, losses are climbing for shorts.

At one point Monday, the stock was up 20%.

S3 Partners’ Ihor Dusaniwsky said Tesla shorts are down $8.3 billion in mark-to-market losses so far in 2020, including almost $2.5 billion in mark-to-market losses on Monday.

Tesla’s stock has climbed nearly 220% in the past six months and passed the $700 a share level for the first time. Dusaniwsky said that, since the stock was under $200 a share in June, Tesla short sellers have covered $12.6 billion worth of stock. That’s a factor that is likely fueling Tesla’s current rally: If enough short sellers buy in tandem, it can create higher demand and itself drive the equity price even higher, a phenomenon also known as “a short squeeze.”

Articles You May Like

Why You May Need To Rethink Your Retirement, Work, And Spending
Trump’s 25% tariff could be an existential threat to Canada’s recovering auto industry
GOP Budget Squabble Puts The Older Americans Act At Risk
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
From Nike to Intel, CEO departures at U.S. companies hit a record this year

Leave a Reply

Your email address will not be published. Required fields are marked *